Vaccine News and Research

Latest Vaccine News and Research

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.

2 Nov 2021

The pros and cons of a COVID-19 vaccine booster

The authors provide an overview of current literature available to assess the need for COVID-19 vaccine booster doses and their potential target population.

2 Nov 2021

End-stage renal disease negatively impacts COVID-19 vaccine response

Researchers perform a systematic review of people with end-stage kidney disease receiving SARS-CoV-2 vaccines to assess their immunogenicity rates.

2 Nov 2021

Research collaboration identifies antibody that limits the severity of coronavirus infections

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

2 Nov 2021

The impacts of the SARS-CoV-2 pandemic on digestive health

The UEG Public Affairs Committee has published a position paper to educate policymakers, patients, healthcare professionals, and the general public about the impacts of the COVID-19 pandemic on digestive health.

2 Nov 2021

The influence of SARS-CoV-2 vaccination time on antibody response in healthcare workers

In this study, the researchers observed a significant effect of time of vaccination on the vaccine-induced SARS-CoV-2 immunity, which was estimated by measuring the anti-Spike antibody levels.

2 Nov 2021

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

A recent study has evaluated vaccine-induced humoral and cellular immunity against SARS-CoV-2 six months post BNT162b2 (Pfizer-BioNTech) vaccination.

2 Nov 2021

‘Not quite on board’: Parents proving a tough sell on covid vax for teens

Even as the U.S. prepares to roll out a covid-19 vaccine to elementary school-aged kids, its efforts to inoculate teenagers — who have been eligible for the shot since May — continue to meet with a lackluster response.

2 Nov 2021

What do we really know about vaccine effectiveness?

The politicization of covid vaccines — and, well, just about everything else having to do with the pandemic — has led to confusion, if not utter fatigue.

2 Nov 2021

SARS-CoV-2 variants neutralized by camel nanobodies

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.

2 Nov 2021

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections.

1 Nov 2021

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

1 Nov 2021

New Australian study identifies key barriers to COVID-19 testing and vaccination

A new study aimed to bridge the gap in a culturally and linguistically diverse population concerning COVID-19 testing intentions and vaccine willingness.

1 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain.

1 Nov 2021

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

1 Nov 2021

Ethnic and socioeconomic disparities persist among U.S. adults who identify as disabled

A new analysis led by Johns Hopkins Medicine researchers finds that the number of U.S. adults who report they have a disability is 27%, representing 67 million adults, an increase of 1% since the data were last analyzed in 2016.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

Armed Forces to support health boards across Scotland in the fight against COVID-19

121 Armed Forces personnel will begin training tomorrow ahead of supporting health boards across Scotland, vaccinating members of the public from Thursday as the Covid-19 vaccine program continues.

1 Nov 2021

More than 8 million people in the UK have taken COVID-19 booster vaccinations

Over eight million people have now received their COVID-19 booster jab, the latest figures show today (Monday 1 November 2021), ensuring the protection they've secured from their first two doses is maintained over the winter months.

1 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

The pros and cons of a COVID-19 vaccine booster

End-stage renal disease negatively impacts COVID-19 vaccine response

Research collaboration identifies antibody that limits the severity of coronavirus infections

The impacts of the SARS-CoV-2 pandemic on digestive health

The influence of SARS-CoV-2 vaccination time on antibody response in healthcare workers

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

‘Not quite on board’: Parents proving a tough sell on covid vax for teens

What do we really know about vaccine effectiveness?

SARS-CoV-2 variants neutralized by camel nanobodies

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New Australian study identifies key barriers to COVID-19 testing and vaccination

New genetic epidemiology tool provides detailed information about viruses, coinfections

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

Ethnic and socioeconomic disparities persist among U.S. adults who identify as disabled

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Armed Forces to support health boards across Scotland in the fight against COVID-19

More than 8 million people in the UK have taken COVID-19 booster vaccinations

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in